𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients

✍ Scribed by Catherine E. Jansen; Bruce A. Cooper; Marylin J. Dodd; Christine A. Miaskowski

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
158 KB
Volume
19
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cognitive function during neoadjuvant ch
Cognitive function during neoadjuvant chemotherapy for breast cancer : Results of a prospective, multicenter, longitudinal study
✍ Kerstin Hermelink; Michael Untch; Michael P. Lux; Rolf Kreienberg; Thomas Beck; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

## Abstract ## BACKGROUND. It is believed widely that chemotherapy‐induced cognitive impairment occurs in a subgroup of patients with breast cancer. However, recent reports have provided no evidence that chemotherapy affects cognition. In this study, the authors questioned whether cognitive compro

Short-term effects of treatment-induced
Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients : Results of a multicenter, prospective, longitudinal study
✍ Kerstin Hermelink; Volkmar Henschel; Michael Untch; Ingo Bauerfeind; Michael Pat πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 258 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. It is suspected that estrogen depletion resulting from treatment may contribute to cognitive compromise in patients with breast cancer. However, the evidence for estrogen effects on cognition is inconclusive, and the consequences of hormonal changes for cognitive functio

Hepatitis B virus reactivation in breast
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
✍ Winnie Yeo; Paul K.S. Chan; Pun Hui; Wing M. Ho; Kwok C. Lam; Wing H. Kwan; Shen πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

## Abstract Breast cancer is a rapidly increasing problem in many developing countries, and cytotoxic chemotherapy is now an integral part of its management. In several developing countries, the carriage of hepatitis B virus (HBV) in cancer patients may be as high as 12%, and such patients are at r